Literature DB >> 19824988

Identifying target groups for the prevention of anxiety disorders in the general population.

N M Batelaan1, F Smit, R de Graaf, A J L M van Balkom, W A M Vollebergh, A T F Beekman.   

Abstract

OBJECTIVE: To avert the public health consequences of anxiety disorders, prevention of their onset and recurrence is necessary. Recent studies have shown that prevention is effective. To maximize the health gain and minimize the effort, preventive strategies should focus on high-risk groups.
METHOD: Using data from a large prospective national survey, high-risk groups were selected for i) the prevention of first ever (n = 4437) and ii) either first-ever or recurrent incident anxiety disorders (n = 4886). Indices used were: exposure rate, odds ratio, population attributable fraction and number needed to be treated. Risk indicators included sociodemographic, psychological and illness-related factors.
RESULTS: Recognition of a few patient characteristics enables efficient identification of high-risk groups: (subthreshold) panic attacks; an affective disorder; a history of depressed mood; a prior anxiety disorder; chronic somatic illnesses and low mastery.
CONCLUSION: Preventive efforts should be undertaken in the selected high-risk groups.

Entities:  

Mesh:

Year:  2009        PMID: 19824988     DOI: 10.1111/j.1600-0447.2009.01488.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  7 in total

1.  Identifying target groups for the prevention of depression among caregivers of dementia patients.

Authors:  Karlijn J Joling; Filip Smit; Harm W J van Marwijk; Henriëtte E van der Horst; Philip Scheltens; Richard Schulz; Hein P J van Hout
Journal:  Int Psychogeriatr       Date:  2011-09-01       Impact factor: 3.878

2.  Predictors of anxiety recurrence in the Coordinated Anxiety Learning and Management (CALM) trial.

Authors:  Jerome H Taylor; Ewgeni Jakubovski; Michael H Bloch
Journal:  J Psychiatr Res       Date:  2015-04-04       Impact factor: 4.791

3.  Validation of the Parental Facilitation of Mastery Scale-II.

Authors:  Alyson K Zalta; Kelly M Allred; Eranda Jayawickreme; Laura E R Blackie; Dianne L Chambless
Journal:  J Clin Psychol       Date:  2016-12-01

4.  Presence and Predictive Value of Obsessive-Compulsive Symptoms in Anxiety and Depressive Disorders.

Authors:  Mieke Klein Hofmeijer-Sevink; Neeltje M Batelaan; Harold J G M van Megen; Marcel A van den Hout; Brenda W Penninx; Anton J L M van Balkom; Danielle C Cath
Journal:  Can J Psychiatry       Date:  2017-05-16       Impact factor: 4.356

Review 5.  Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.

Authors:  Martin A Katzman; Pierre Bleau; Pierre Blier; Pratap Chokka; Kevin Kjernisted; Michael Van Ameringen; Martin M Antony; Stéphane Bouchard; Alain Brunet; Martine Flament; Sophie Grigoriadis; Sandra Mendlowitz; Kieron O'Connor; Kiran Rabheru; Peggy M A Richter; Melisa Robichaud; John R Walker
Journal:  BMC Psychiatry       Date:  2014-07-02       Impact factor: 3.630

6.  Prevention of anxiety disorders in primary care: a feasibility study.

Authors:  Neeltje M Batelaan; Jan H Smit; Pim Cuijpers; Harm W J van Marwijk; Berend Terluin; Anton J L M van Balkom
Journal:  BMC Psychiatry       Date:  2012-11-22       Impact factor: 3.630

Review 7.  Risk of relapse after antidepressant discontinuation in anxiety disorders, obsessive-compulsive disorder, and post-traumatic stress disorder: systematic review and meta-analysis of relapse prevention trials.

Authors:  Neeltje M Batelaan; Renske C Bosman; Anna Muntingh; Willemijn D Scholten; Klaas M Huijbregts; Anton J L M van Balkom
Journal:  BMJ       Date:  2017-09-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.